Helical graft
09572694 ยท 2017-02-21
Assignee
Inventors
Cpc classification
A61F2/915
HUMAN NECESSITIES
A61F2002/91508
HUMAN NECESSITIES
A61F2002/068
HUMAN NECESSITIES
B29C65/00
PERFORMING OPERATIONS; TRANSPORTING
A61F2002/91516
HUMAN NECESSITIES
International classification
A61F2/915
HUMAN NECESSITIES
Abstract
A graft includes a flow tubing having a tubing portion defining a flow lumen. The flow lumen of the tubing portion is substantially free of ribs or grooves. A center line of the flow lumen follows a substantially helical path with a helix angle less than or equal to 65. The amplitude of the helix is less than or equal to one half of the internal diameter of the tubing portion.
Claims
1. A method of inhibiting flow instability in a graft for biomedical use, the graft comprising flow tubing which is for use in vivo to carry blood and which is made of biocompatible material, the flow tubing having a tubing portion with an internal diameter and defining a flow lumen, wherein the flow lumen of the tubing portion is of circular cross-section, the flow lumen of said tubing portion having a centre line and being substantially free of ribs or grooves, wherein the graft is thermally set such that it retains a twisted shape and the centre line of the flow lumen follows a helical path about a longitudinal axis so as to define a helical center line, the helical center line having a helix angle and a helix amplitude, the helix angle being less than or equal to 45, and the helix amplitude being less than or equal to one half of the internal diameter of the tubing portion, and wherein the flow tubing is flexible and is capable of adopting a configuration in which the longitudinal axis is curved and the helical center line of the tubing portion follows a helical path about the curved longitudinal axis.
2. A method as claimed in claim 1, wherein the amplitude of the helical center line divided by the internal diameter of the tubing is at least 0.05.
3. A method as claimed in claim 1, wherein the helix angle is less than or equal to 15.
4. A method as claimed in claim 1, wherein the centre line of the tubing portion follows a substantially helical path about an axis which is curved.
5. A method as claimed in claim 1, wherein the graft further comprises a pharmaceutical coating.
6. A method as claimed in claim 1, wherein the tubing portion comprises a tubular wall which resists reduction of the amplitude of the helical centre line.
7. A method as claimed in claim 1, wherein the graft is thermally shape set.
8. A method as claimed in claim 1, wherein the tubing portion has a wall comprising a helical winding to help maintain a circular cross-section of the flow lumen.
9. A method as claimed in claim 8, wherein the helix angle of the helical winding is larger than the helix angle of the helical centre line of the flow lumen.
10. A method as claimed in claim 1, wherein the graft comprises ePTFE.
11. A method of inhibiting flow instability in a graft for biomedical use, the graft comprising flow tubing which is for use in vivo to carry blood and which is made of biocompatible material, the flow tubing having a tubing portion with an internal diameter and defining a flow lumen, wherein the flow lumen of the tubing portion is of circular cross-section, wherein the graft is thermally set such that it retains a twisted shape and the center line of the flow lumen follows a helical path about a longitudinal axis so as to define a helical center line, the helical center line having a helix angle and, a helix amplitude, the helix angle being less than or equal to 45, the helix amplitude being less than or equal to one half of the internal diameter of the tubing portion, and the amplitude of the helical centre line divided by the internal diameter of the tubing portion is at least 0.05, and wherein the flow tubing is flexible and is capable of adopting a configuration in which the longitudinal axis is curved and the helical center line of the tubing portion follows a helical path about the curved longitudinal axis.
12. A method as claimed in claim 11, wherein the helix angle is less than or equal to 15.
13. A method as claimed in claim 11, wherein the center line of the tubing portion follows a substantially helical path about an axis which is curved.
14. A method as claimed in claim 11, wherein the graft further comprises a pharmaceutical coating.
15. A method as claimed in claim 11 wherein the tubing portion comprises a tubular wall which resists reduction of the amplitude of the helical center line.
16. A method as claimed in claim 11, wherein the graft is thermally shape set.
17. A method as claimed in claim 11, wherein the tubing portion has a wall comprising a helical winding to help maintain a circular cross-section of the flow lumen.
18. A method as claimed in claim 11, wherein the helix angle of the helical winding is larger than the helix angle of the helical center line of the flow lumen.
19. A method as claimed in claim 11, wherein the graft comprises ePTFE.
Description
BRIEF DESCRIPTION OF THE DRAWINGS
(1) Certain preferred embodiments of the invention will now be described by way of example and with reference to the accompanying drawings, in which:
(2)
(3)
(4)
(5)
(6)
(7)
(8)
(9)
(10)
(11)
(12)
(13)
(14)
(15)
(16)
DETAILED DESCRIPTION
(17) The tubing portion 1 shown in
(18) It will be seen that the amplitude A is less than the tubing internal diameter D.sub.I. By keeping the amplitude below this size, the space occupied by the tubing portion can be kept relatively small, whilst at the same time the helical configuration of the tubing portion promotes swirl flow of fluid along the tubing portion.
(19)
(20) Blood from the circulatory system can flow from the inlet 2 to the outlet 3 along a hollow interior or lumen 4. The helically formed tubing portion 1 is disposed adjacent to the outlet 3. Its non-planar curvature induces a swirl to the flow to improve circulation by rendering the distribution of wall shear stress relatively uniform and suppressing flow separation and flow instability, and as a result inhibiting the development of vessel pathology. The swirl flow may also resist the build up of intimal hyperplasia at the join and downstream of the join with the vein or artery. The tubing can be made of suitable bio-compatible material and such materials are commercially available and known to those skilled in the art. In order to maintain the tubing open and prevent collapse or kinking it is possible to use a stent or other structural support of plastic, metal or other material internally, externally or integral to the wall of the tubing.
(21) It will be seen that the prosthesis 10 in
(22) The arrangement of
(23) Part of the envelope 20 within which the tubing portion 1 is defined is shown in
(24) The vascular graft 10 shown in
(25) The tubing 1 has a helical portion 6 extending longitudinally and circumferentially with the same pitch as pitch P of the helical centre line 40. The helical portion 6 consists of a strip of material secured to the wall 62 of the tubing 1.
(26) The tubing 1 has an inlet 2 at one end and an outlet 3 at the other end. The tubing has inlet 2a and outlet 3a flaps at its ends which have been surgically fastened by suturing to regions of an artery 8 remote from a blockage 7 in the artery, the graft 10 thus acting as an arterial bypass graft. It could also be surgically connected between an artery and a vein so as to serve as a vascular access graft for e.g. renal dialysis.
(27) Blood from the circulatory system can flow from the inlet 2 to the outlet 3 along a hollow interior or lumen 4 of the graft 10. It operates in a manner similar to the graft of
(28) The tubing 1 may be made of various materials. Suitable bio-compatible materials are commercially available and known to those skilled in the art. One suitable material is polyester. A knitted polyester yarn such as polyethylene terephthalate, known as Dacron (trade mark) is a particular example. The helical portion may be made of the same material or another material, such as polypropylene. The helical portion, rather than being a separate strip secured to the wall 62 of the tubing 1, may be an integral part thereof, for example by being knitted or stitched in to the wall.
(29)
(30) It will be seen that the inflated balloon 55 has a helical lumen. As with the tubing for fluid flow, it has a helical centre line 40, which follows a helical path about a longitudinal axis 30. The longitudinal axis is at the centre of an imaginary cylindrical envelope 20 within which the balloon is contained. The amplitude A of the helix is shown in
(31) It will be noted that after inflation the straight line 50 adopts a wave shape which remains consistently along the same side of the balloon, so that the entire line 50 remains visible in the elevation view of
(32) The balloon of
(33) The balloon is internally pressurised in a manner to some extent analogous with the internal pressurisation of the tubing of the preferred embodiments of the invention. The helical portion causes what would otherwise be a cylindrical shape to adopt and maintain helical geometry. A similar effect is obtained by the helical portion of the tubing for body fluid flow, wherein the helical portion tends to help the tubing maintain its helical longitudinal cavity, i.e. to resist straightening out.
(34) A tubing having a wall defining a longitudinally extending cavity having a centre line following a substantially helical path was manufactured as follows.
(35) A pair of flexible cylindrical tubes made from polyester were internally supported by insertion of respective closely fitting coiled springs. The two supported tubes were then positioned adjacent to each other and twisted around each other. The pair of tubes were thermoset in the twisted configuration by immersion in hot water followed by removal and cooling. The tubes were separated and the coil springs removed. The internal geometry of each tube so formed consisted of a longitudinally extending cavity having a centre line following a substantially helical path. One of the tubes was subjected to internal pressurisation by insertion of a cylindrical balloon which was then gently inflated. Because of the flexible nature of the material forming the tube, the effect of the internal pressurisation was to straighten out the helix, in that the pitch was increased and the amplitude decreased.
(36) Such a straightening out effect is however resisted by the use of a helical portion applied to the tube, as described herein. The helical portion is applied to each of the tubes before they are deformed and thermoset as described above. During the step of twisting the two tubes around each other, they are positioned so that their respective helical portions lie in contact with each other.
(37) A similar method was used to manufacture another tubing having a wall defining a longitudinally extending cavity with a centre line following a substantially helical path. In this case, the tubing was made of expanded polytetrafluoroethylene (ePTFE). Biocompatible tubing of this type is available for use as vascular prostheses, for example from Vascutek Limited or Boston Scientific Corporation.
(38) Referring to
(39) A test was carried out on the tubing 1 to investigate its ability to maintain its helical geometry. One end was clamped and the other end was connected to a water supply at a pressure head of 1.5 meters (roughly equal to blood pressure). It was observed that the helical geometry was maintained after 24 hours.
(40)
(41) In an alternative manufacturing method, only one tube, rather than two, is used. The method is described with reference to
(42) In a preferred method a knitted polyester yarn such as polyethylene terephthalate, known as Dacron (trade mark), is a suitable material for the tube, whilst the elongate member may be polypropylene. The tube may be externally supported with helically wound (with a very large helix angle, close to 90) polypropylene. With these materials the heating step is carried out by heating the tube and tensioned thread in an oven at 140 C.
(43) In another alternative manufacturing method using only one tube, the tube is initially cylindrical, with a helical portion extending along its wall. The method is described with reference to
(44) The helical portion, in the form of strip 51, thus serves the purposes first of creating the helical geometry during the inflation step, and later of helping to retain that geometry when the tube is used and internally pressurised by e.g. arterial pressure.
(45) Another method of making a graft is described with reference to
(46)
(47) In order to form a helical portion, a length of straight flexible tube 1, whose external diameter D.sub.E is greater than the internal diameter D.sub.M of the core of the mandrel, is fed generally along the core of the mandrel, as shown in
(48) After being treated to make it retain its helical shape, e.g. by thermosetting, the tube is removed from the mandrel, as shown in
(49) As can be seen, the pitch of the helical portion is the same as the pitch of the mandrel, subject to some possible relaxation of the tube when removed from the mandrel. The amplitude of the helical portion will be determined by the external diameter of the tube and the internal diameter of the core of the mandrel.
(50) The above description concerns a batch processing method for forming the helical tubing, but this method also lends itself to continuous operation. A continuous length of flexible tube can be drawn through a comparatively short length of mandrel, and can be treated to retain its shape as it is drawn through (for example, by heating and then cooling a tube formed from a thermosetting resin).
(51) Experiment has shown that the tube rotates relative to the mandrel when it is drawn through in this way. Thus, some form of lubrication may be required to enable smooth functioning of the process.
(52)
(53) The mandrel can be formed in any suitable manner, and the method of forming the mandrel will depend to a large extent on the size of the tubes being treated. The mandrel could be formed by winding a rod around a member with a circular cross-section, or it may be made by machining, for example using a CNC milling machine.
(54) Another method of making a graft is described with reference to
(55) The tubing is then heated and cooled in order to thermoset it. It is separated from the rod and when it separates it relaxes whereby its helical amplitude reduces. In this example, the tubing is made of ePTFE.
EXAMPLE 1
(56) Experiments were carried out using polyvinyl chloride tubing with a circular cross-section. Referring to the parameters shown in
2A=WD.sub.E
So:
(57)
(58) In this example the swept width W was 14 mm, so:
(59)
(60) As discussed earlier, relative amplitude A.sub.R is defined as:
(61)
(62) In the case of this Example, therefore:
(63)
(64) Water was passed along the tube. In order to observe the flow characteristics, two needles 80 and 82 passing radially through the tube wall were used to inject visible dye into the flow. The injection sites were near to the central axis 30, i.e. at the core of the flow. One needle 80 injected red ink and the other needle 82 blue ink.
(65)
EXAMPLE 2
(66) The parameters for this Example were the same as in Example 1, except that the needles 80 and 82 were arranged to release the ink filaments 84 and 86 near to the wall of the tubing.
(67) It will be appreciated that this invention, in its first aspect, is concerned with values of relative amplitude A.sub.R less than or equal to 0.5, i.e. small relative amplitudes. In a straight tubing portion both the amplitude A and the relative amplitude A.sub.R equal zero, as there is no helix. Therefore, with values of relative amplitude A.sub.R approaching zero, the ability of the tubing portion to induce swirl will reduce. The lowest workable value of relative amplitude A.sub.R for any given situation will depend on the speed of flow and the viscosity and density of the fluid (i.e. Reynolds number) and on the pitch (helix angle) and the particular use of the tubing portion. Relative amplitudes of at least 0.05, 0.10, 0.15, 0.20, 0.25, 0.30, 0.35, 0.40 or 0.45 may be preferred.
(68) The various manufacturing methods described herein are not limited to the manufacture of tubing with a relative amplitude equal to or less than 0.5, unless otherwise specified. The methods are considered to be of independent patentable significance and are applicable to the manufacture of tubing with larger amplitudes, whilst also being particularly useful for making tubing of small relative amplitudes.